Back to UBS Group AG UBS Group AG

BNTCBNTC
Showing 8 of 12 quarters

Position history for UBS Group AGUBS Group AG's holdings in BENITEC BIOPHARMA INC

UBS Group AG holds 125,431 shares of BNTC (BENITEC BIOPHARMA INC), worth $1.7M as of 2026-Q2. The position was increased (+8.3% shares). BNTC represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.7M

Current Shares

125,431

Total Value Change

+$1.7M

Total Shares Change

+123,507

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
125,431
+8.3%
$1.7M0.0%$13.38
28
2026-Q1
Increased
115,819
+17.8%
$1.2M0.0%$10.46
30
2025-Q4
Decreased
98,347
-1.6%
$1.3M0.0%$13.93
0
2025-Q3
Increased
99,941
+458.8%
$1.4M0.0%$13.99
41
2025-Q2
Increased
17,884
+78.6%
$209,2420.0%$11.35
24
2025-Q1
Increased
10,012
+99.7%
$130,2560.0%$13.43
24
2024-Q4
Increased
5,013
+160.6%
$63,3140.0%$12.51
23
2024-Q3
Decreased
1,924
-5.3%
$17,6810.0%$9.23
0

Other major holders of BNTC: Janus Henderson Group Ltd., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used